CN1216610C - Rheumatism treating medicine - Google Patents
Rheumatism treating medicine Download PDFInfo
- Publication number
- CN1216610C CN1216610C CN991193253A CN99119325A CN1216610C CN 1216610 C CN1216610 C CN 1216610C CN 991193253 A CN991193253 A CN 991193253A CN 99119325 A CN99119325 A CN 99119325A CN 1216610 C CN1216610 C CN 1216610C
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- medicine
- radix
- rheumatic arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to medicine for mainly treating rheumatic arthritis, which matches a family handed recipe and a Chinese medicine principle, and the medicine for mainly treating rheumatic arthritis mainly comprises radix aconiti, pubescent angelica roots, long-noded pit vipers, pangolins, pricklyash and scorpion. The medicine for mainly treating rheumatic arthritis can remove stagnated heat and lighten ailment, and the medicine for mainly treating rheumatic arthritis has the advantages of low cost, easy raw material taking and no side effect.
Description
Technical field
The present invention relates to a kind of medicine that cures mainly rheumatism, rheumatoid arthritis.
Background technology
At present the drug main in treatment rheumatic and rheumatoid joint will be used: dioxygen painful, the ZHUANGGU GUANJIE WAN of going out, ibuprofen.Though these medicines have certain curative effect, but the phase in next life, fundamental symptoms also can not get control, caused disease to subtract the harmful effect that disease is advanced, and the purpose of this invention is to provide a kind of rheumatism, rheumatoid arthritis of curing, cure rate can reach more than 90%, and the medicine that does not recur, has no side effect.
Summary of the invention
The present invention adopts following principle to realize: the flourish muscle of the strong bone nourishing the liver of strengthening vital QI to eliminate pathogenic factors is searched the principle of wind analgesic therapy, control wind and control blood earlier, the blood sector-style is from going out, modern medical theory belongs to streptococcal infection with it and draws except that wind and cold is wet, so with body get/outbreak repeatedly appears in kilogram amount penicillin, streptomycin, the damp and hot multiple abscess joint that the present invention causes with wet three heresies of wind and cold, with the passing of time and symptoms such as fire-transformation.It is existing that the handy more back of medication of the present invention does not have the recurrence mark, thereby visible medicine of the present invention is the arthritic specific medicament of treatment rheumatic and rheumatoid, subtracts disease and advance thereby changed disease.The lighter's heavy person three months recovery from illness of fully recovering in month makes rheumatism point rheumatic sufferers alleviate disease and advances.Reduced disability rate, reduced positive position, the harmful effect of ankylosis.The present invention meets the epoch national conditions.Generation of the present invention has reduced rheumatismal sickness rate.The concrete prescription of the present invention can be with reference to following composition by weight than compatibility:
Radix Aconiti 3-15 gram, Radix Aconiti Kusnezoffii 3-15 gram,
Herba Lycopi 6-15 gram, Agkistrodon 3-10 gram,
LISHEN 6-15 gram, Squama Manis 6-18 gram,
Radix Clematidis 6-15 gram, Pericarpium Zanthoxyli 10 grams,
Radix Salviae Miltiorrhizae 10-30 gram, Caulis Spatholobi 10-30 gram,
Herba Cistanches 10-30 gram, Scorpio 6-10 gram.
Owing to adopt such scheme, can make the present invention treat rheumatism point rheumatic arthritis and reach cure rate more than 90%, and have no side effect.Compare with existing common drug that cost is low, curative effect fast, cure rate improves greatly.
Specific embodiments
Below be this pharmaceutical formulation and processing technology: Radix Aconiti Kusnezoffii 3 grams, Radix Aconiti 3 grams, Herba Lycopi's 6 grams, 3 of Agkistrodons, Scorpio 6 grams, LISHEN 6 grams, Squama Manis 6 grams, Radix Clematidis 6 grams, Pericarpium Zanthoxyli 10 grams, Radix Salviae Miltiorrhizae 10 grams, Caulis Spatholobi 10 grams, Herba Cistanches 10 grams, Rhizoma Et Radix Notopterygii 6 grams, Radix Saposhnikoviae 6 grams, Radix Angelicae Pubescentis 6 grams, wherein the each component roguing is cleaned, the sub-parching to brown of Pericarpium Zanthoxyli, Scorpio salt is fried, and the husky big gun vinegar of Squama Manis is liquor-saturated to be the fine flour honeyed pill altogether.
Claims (2)
1, a kind of medicine for the treatment of rheumatism, rheumatoid arthritis is characterized in that it is made up of following materials of weight proportions medicine:
Radix Aconiti 3-15 gram, Radix Aconiti Kusnezoffii 3-15 gram,
Herba Lycopi 6-15 gram, Agkistrodon 3-10 gram,
LISHEN 6-15 gram, Squama Manis 6-18 gram,
Radix Clematidis 6-15 gram, Pericarpium Zanthoxyli 10 grams,
Radix Salviae Miltiorrhizae 10-30 gram, Caulis Spatholobi 10-30 gram,
Herba Cistanches 10-30 gram, Scorpio 6-10 gram.
2, a kind of medicine for the treatment of rheumatism, rheumatoid arthritis is characterized in that it is made up of following materials of weight proportions medicine:
Radix Aconiti Kusnezoffii 3 grams, Radix Aconiti 3 grams, Herba Lycopi's 6 grams, 3 of Agkistrodons, Scorpio 6 grams, LISHEN 6 grams, Squama Manis 6 grams, Radix Clematidis 6 grams, Pericarpium Zanthoxyli 10 grams, Radix Salviae Miltiorrhizae 10 grams, Caulis Spatholobi 10 grams, Herba Cistanches 10 grams, Rhizoma Et Radix Notopterygii 6 grams, Radix Saposhnikoviae 6 grams, Radix Angelicae Pubescentis 6 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN991193253A CN1216610C (en) | 1999-09-09 | 1999-09-09 | Rheumatism treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN991193253A CN1216610C (en) | 1999-09-09 | 1999-09-09 | Rheumatism treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1247761A CN1247761A (en) | 2000-03-22 |
| CN1216610C true CN1216610C (en) | 2005-08-31 |
Family
ID=5280834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN991193253A Expired - Fee Related CN1216610C (en) | 1999-09-09 | 1999-09-09 | Rheumatism treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1216610C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972464B (en) * | 2010-10-29 | 2011-12-14 | 韩世昌 | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
-
1999
- 1999-09-09 CN CN991193253A patent/CN1216610C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1247761A (en) | 2000-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1554413A (en) | Chinese medicine for treating urolithiasis and its preparing method | |
| CN101062198A (en) | Decoction for treating arthritis | |
| CN101152299A (en) | Traditional Chinese medicine for treating goiter and tumor | |
| CN101152554A (en) | Traditional Chinese medicine for treating urticaria, namely clearing heat and eliminating rash | |
| CN1216610C (en) | Rheumatism treating medicine | |
| CN102872301A (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN1406594A (en) | Oral Chinese medicine for osteoarthritis | |
| CN1276229A (en) | Chinese medicine preparation for treating scrofula and its preparing process | |
| CN101152343A (en) | Traditional Chinese medicine for treating chronic dacryocystitis | |
| CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
| CN102614330B (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN101129637A (en) | Traditional Chinese Medicine for Treating Vascular Headache | |
| CN1279948C (en) | Medicine for treating arthritis and atrophic arthritis | |
| CN1229118C (en) | Bone setting medicine | |
| CN102940837A (en) | Chinese medicinal composition for treating migraine | |
| CN1089160A (en) | " Biantianfengshiqing " medicine for treating rheumatism | |
| CN101129694A (en) | Traditional Chinese medicine for treating muscular contraction headache | |
| CN101152534A (en) | Traditional Chinese medicine for treating old fracture | |
| CN101152537A (en) | Traditional Chinese medicine for treating hysteria syncope of women | |
| CN1273167C (en) | Medicine for external application for curing rheumatism and its preparation method | |
| CN1069526C (en) | Medicine for curing hyperosteogeny | |
| CN104324190A (en) | External traditional Chinese medicine for treating mouse hand and preparation method thereof | |
| CN101167845A (en) | Traditional Chinese medicine for treating children's winks | |
| CN101306170B (en) | Traditional Chinese medicinal preparation for fracture setting | |
| CN1369298A (en) | Capsule for treating hemiplegia and rheumatism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |